An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease

Abroad (travel likely)Recruiting

Conditions

Systemic Lupus Erythematosus · Systemic Sclerosis · Inflammatory Myopathy · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis · Antiphospholipid Syndrome · Sjogren's Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shanghai Changzheng Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Huji Xu) · xuhuji@smmu.edu.cn · 8602181886999

Study leads

Huji Xu, MD,Ph.D
Principal Investigator
Shanghai Changzheng Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Rheumatology Patient Registry and Biorepository

Rheumatic Diseases · Adult Onset Still Disease · Ankylosing Spondylitis

Abroad (travel likely)Recruiting

New Haven, United States

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

Systemic Lupus Erythematosus · Inflammatory Myopathy · Systemic Sclerosis (SSc)

Abroad (travel likely)RecruitingPHASE2

Beijing, China

Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

Autoimmune Diseases · Systemic Lupus Erythematosus · Systemic Sclerosis

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China

US Zamto-cel Autoimmune Diseases

Lupus Nephritis · Systemic Lupus Erythematosus · Systemic Sclerosis (SSc)

Abroad (travel likely)RecruitingPHASE1

Milwaukee, United States